M

MRK

Merck & Co., Inc.
HealthcareDrug Manufacturers - General|New York Stock Exchange|US

Price

$120.87

Market Cap

$298.84B

Beta

0.26

P/E

16.4

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+1.31%
EPS Growth (YoY)+8.17%
Revenue CAGR 3Y+3.12%
P/E Ratio16.4
PEG Ratio2.03
FCF Yield+4.14%
Debt / Equity0.96
Interest Coverage28.3x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for MRK.

MRK — Merck & Co., Inc. Stock Analysis | Tessera Alpha